Drug intelligence / Profile preview

9E,11E-conjugated linoleic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

9E,11E-conjugated linoleic acid (9E,11E-CLA), also known as isolinoleic acid or Mangold's acid, is a specific geometric isomer of linoleic acid with two contiguous double bonds in the all-trans configuration at positions 9 and 11. It is a naturally occurring polyunsaturated fatty acid found in trace amounts in beef fat and dairy products. Unlike more common CLA isomers (such as 9-cis,11-trans), the 9E,11E isomer has demonstrated unique and potent anti-inflammatory, anti-carcinogenic, and anti-atherogenic properties in preclinical research. Its mechanism of action primarily involves the induction of the endogenous anti-inflammatory factor interleukin-1 receptor antagonist (IL-1Ra) through the activation of the phosphoinositide 3-kinase (PI3K) and mechanistic target of rapamycin (mTOR) signaling pathways. This activity leads to the downregulation of several atherogenesis-related genes, including adhesion molecules like ICAM-1 and VCAM-1, and chemokines such as MCP-1. While it shows significant biological potential, 9E,11E-CLA is currently utilized primarily as a research chemical and is not in formal pharmaceutical development by any identified commercial entity.

Other names
9E,11E-CLAisolinoleic acidMangold's acidtrans-9,trans-11-octadecadienoic acid(9E,11E)-octadeca-9,11-dienoic acid9-trans,11-trans-octadecadienoic acid
02

Targets

IL1RN (Interleukin-1 receptor antagonist)mTOR (Mammalian target of rapamycin kinase)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)

Beyond the preview

Go deeper on 9E,11E-conjugated linoleic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 9E,11E-conjugated linoleic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call